Events

2011

	11 October. The Aqix Team will be at Innovate'11 taking place at the Business Design Centre, Islington, London on Tuesday 11 October 2011 and will be available for discussions related to the AQIX® RS-I technology, collaboration opportunities and funding discussions as part of the current £1.5 million funding round.
	05 October. Matthew Durdy, CEO at Aqix Ltd presented the AQIX® RS-I investment opportunitiy to the Queen Mary Bioenterprises Biotechnology Investment Forum as part of a £1.5 million funding round. The event was held at the QMB Innvoation Centre, London.
	20 September. Matthew Durdy, CEO at Aqix Ltd presented the AQIX® RS-I opportunitiy to the Oxford Investment Opportunity Netwerk (OION) as part of a £1.5 million funding round.
	23 March. Dr. Darren Stevenson, Head of Product Development at Aqix Ltd will attending the Developing Therapeutics 2 competition launch looking for further collaboration opportunities for exploitation of the companies lead product, AQIX® RS-I, a synthetic interstitial fluid.
	January 8th – 14th 2011. Matthew Durdy, Chief Executive Officer at Aqix Ltd will be travelling on the UK's future health mission to San Francisco to present on Aqix Ltd and AQIX® RS-I. During this event Matthew will be interviewed by Dr. Moira Gunn on the intravenous applications and clinical need for AQIX® RS-I. A copy of this interview is available in the Mediacentre - Video section of the website.

2010

Dr. Darren Stevenson, Head of Product Development at Aqix Ltd will be attending the Collaboration Nation Event - Exploiting Market Opportunities in Regenerative Medicine to be held at the King’s Fund. Again Aqix Ltd will be looking for new collaborations for its lead product, AQIX® RS-I, a synthetic interstitial fluid, that fit within the current regenerative medicine calls from the Technology Strategy Board.

Matthew Durdy will be presenting the result of the Aqix Ltd feasibility project funded by the Technology Strategy Board. A copy of this presentation is available in the Mediacentre - Video section of the website.

24 March, London. Aqix Ltd to attend the Regenerative Medicine Workshop TSB New Funding Opportunities for Regenerative Medicine: Ensuring Best Success for Building your Consortium and Preparing Proposals. Dr. Darren Stevenson, Head of Product Development and Matthew Durdy, Chief Executive Officer, will be in attendance and looking for new collaborations for its lead product, AQIX® RS-I, a synthetic interstitial fluid, that fit within future regenerative medicine calls from the Technology Strategy Board.

16-19 March, Kensington, London. Dr. Darren Stevenson will be attending the British Transplant Society annual congress to investigate further collaborations in relation to the organ transplant perfusion application for AQIX® RS-I.